We often write on the latest developments in cancer research and mesothelioma treatment. As research progresses, there are often new and exciting developments to share. Still, the best treatment for many patients often remains a combination of chemotherapy and radiation, according to recently published guidelines by the American Society of Clinical Oncology.
Expert panel issues recommendation on mesothelioma treatment
ASCO gathered medical experts in a variety of fields, including oncology, imaging, thoracic surgery and pathology to systemically review research and literature on pleural mesothelioma. The panel used observational studies published since 1990 in making their determinations and found 222 studies that informed the basis of their recommendations.
Minor changes in new guidelines
The guidelines are intended for medical professionals and therefore complex and dense with medical terminology. However, it is available publicly and patients are welcome to read them. The panel asked — and answered — five questions:
- What is the best way to get an accurate mesothelioma diagnosis?
- How should medical professionals assess a patient before making recommendations?
- What are the best first and second treatment options?
- When is surgery appropriate?
- When is radiation treatment appropriate?
In all, the panel made over 60 recommendations for diagnosing and treating pleural malignant mesothelioma. Doctors can use these guidelines to help discuss treatment options with patients based on the patient’s individual circumstances.
Panel addresses new developments in research
While many of the recommendations remain similar to past treatments, the panel did discuss recent developments. According to the panel, significant recent advances have identified new potential treatment options, particularly certain drugs. However, the panel ultimately concluded that some of the research, while promising, was not yet established enough to warrant a recommendation.